- Home
- GTBP vs SINT Comparison
GTBP vs SINT Comparison
Compare GTBP & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTBP | SINT |
|---|---|---|
| Founded | 1965 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 11.8M |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GTBP | SINT |
|---|---|---|
| Price | $3.97 | $1.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 62.9K | 28.7K |
| Earning Date | 11-20-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.75 | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,018,000.00 |
| Revenue This Year | N/A | $217.16 |
| Revenue Next Year | N/A | $86.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.22 | $1.40 |
| 52 Week High | $287.50 | $4.46 |
Technical Indicators
Market Signals| Indicator | GTBP | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 29.33 | 36.09 |
| Support Level | $0.22 | $1.51 |
| Resistance Level | $7.50 | $1.89 |
| Average True Range (ATR) | 0.41 | 0.12 |
| MACD | 0.16 | -0.02 |
| Stochastic Oscillator | 1.05 | 34.15 |
Price Performance
Historical ComparisonAbout GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.